Identification of a K(d)-restricted antigenic peptide encoded by murine cytomegalovirus early gene M84

Journal of General Virology

Volumn 81, Issue 12, 2000, Pages 3037-3042

  Holtappels, R ^a   Thomas, D ^a   Reddehase, M J ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MATRIX PROTEIN; PEPTIDE; VIRUS ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN PRESENTATION; ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS; EARLY RESPONSE GENE; GENE EXPRESSION; IMMUNITY; MAJOR HISTOCOMPATIBILITY COMPLEX RESTRICTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; VIRUS GENE;

EID: 0034535281     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/0022-1317-81-12-3037     Document Type: Article

References (26)

1. CD28 interaction with B7 co-stimulates primary allogeneic proliferative responses and cytotoxicity mediated by small, resting T lymphocytes
2. Recognition of human cytomegalovirus gene products by HCMV-specific cytotoxic T cells
3. Human cytomegalovirus-specific cytotoxic T cells. Relative frequency of stage-specific CTL recognizing the 72-kDa immediate-early protein and glycoprotein B expressed by recombinant vaccinia viruses
4. Analysis of the protein-coding content of the sequence of human cytomegalovirus strain AD169
5. Identification, analysis, and evolutionary relationships of the putative murine cytomegalovirus homologs of the human cytomegalovirus UL82 (pp71) and UL83 (pp65) matrix phospho-proteins
6. Efficient processing of an antigenic sequence for presentation by MHC class I molecules depends on its neighboring residues in the protein
7. Protection against lethal cytomegalovirus infection by a recombinant vaccine containing a single nonameric T-cell epitope
8. The cleavage preference of the proteasome governs the yield of antigenic peptides
9. Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules
10. DNA immunization confers protection against murine cytomegalovirus infection
11. Immune evasion by cytomegalovirus - Survival strategies of a highly adapted opportunist
12. Control of murine cytomegalovirus in the lungs: Relative but not absolute immunodominance of the immediate-early 1 nonapeptide during the antiviral cytolytic T-lymphocyte response in pulmonary infiltrates
13. The putative natural killer decoy early gene m04 (gp34) of murine cytomegalovirus encodes an antigenic peptide recognized by protective antiviral CD8 T cells
14. Target structures of the CD8+ T-cell response to human cytomegalovirus: The 72-kilodalton major immediate-early protein revisited
15. A mouse cytomegalovirus glycoprotein, gp34, forms a complex with folded class 1 MHC molecules in the ER which is not retained but is transported to the cell surface
16. Identification of the major late human cytomegalovirus matrix protein pp65 as a target antigen for CD8+ virus-specific cytotoxic T lymphocytes
17. In vivo replication, latency, and immunogenicity of murine cytomegalovirus mutants with deletions in the M83 and M84 genes, the putative homologs of human cytomegalovirus pp65 (UL83)
18. Suppression of murine cytomegalovirus (MCMV) replication with a DNA vaccine encoding MCMV M84 (a homolog of human cytomegalovirus pp65)
19. Analysis of the complete DNA sequence of murine cytomegalovirus
20. The immunogenicity of human and murine cytomegaloviruses
21. A pentapeptide as minimal antigenic determinant for MHC class I-restricted T lymphocytes
22. Generation of cytomegalovirus-specific human T-lymphocyte clones by using autologous B-lymphoblastoid cells with stable expression of pp65 or IE1 proteins: A tool to study the fine specificity of the antiviral response
23. Presentation of three different viral peptides, HTLV Tax, HCMV gB, and influenza virus M1, is determined by common structural features of the HLA-A2.1 molecule
24. The human cytotoxic T-lymphocyte (CTL) response to cytomegalovirus is dominated by structural protein pp65: Frequency, specificity, and T-cell receptor usage of pp65-specific CTL
25. A mouse cytomegalovirus glycoprotein retains MHC class 1 complexes in the ERGIC/cis-Golgi compartments